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ABSTRACT
With the expansion of the RNA world, antisense
strategies have become widespread to manipulate
nuclear gene expression but organelle genetic sys-
tems have remained aside. The present work opens
the field to mitochondria. We demonstrate that
customized RNAs expressed from a nuclear trans-
gene and driven by a transfer RNA-like (tRNA-like)
moiety are taken up by mitochondria in plant cells.
The process appears to follow the natural tRNA
import specificity, suggesting that translocation
indeed occurs through the regular tRNA uptake
pathway. Upon validation of the strategy with a
reporter sequence, we developed a chimeric cata-
lytic RNA composed of a specially designed trans-
cleaving hammerhead ribozyme and a tRNA mimic.
Organelle import of the chimeric ribozyme and
specific target cleavage within mitochondria were
demonstrated in transgenic tobacco cell cultures
and Arabidopsis thaliana plants, providing the first
directed knockdown of a mitochondrial RNA in a
multicellular eukaryote. Further observations point
to mitochondrial messenger RNA control mechan-
isms related to the plant developmental stage and
culture conditions. Transformation of mitochondria
is only accessible in yeast and in the unicellular alga
Chlamydomonas. Based on the widespread tRNA
import pathway, our data thus make a breakthrough
for direct investigation and manipulation of mito-
chondrial genetics.
INTRODUCTION
In eukaryotic cells, mitochondria ensure fundamental
functions in energy production, redox processes,
metabolic pathways and apoptosis. The genetic system pre-
sent in these cytoplasmic organelles is thus of primary rele-
vance for cell survival. The mammalian mitochondrial
DNA is a small and compact molecule of 16.5kb contain-
ing no intergenic regions or introns (1). Gene expression
driven by promoters located in the single non-coding
region involves a number of speciﬁc transcriptional and
post-transcriptional steps (2). Higher plant mitochondria
possess large genomes in which over half of the sequences
are unassigned (3), but there is no reverse genetics
approach available to probe for function. Plant mitochon-
drial gene expression is complex, including cis- and trans-
splicing of introns (4), RNA processing and surveillance
(5), as well as RNA editing (6). Many aspects of mito-
chondrial genetic processes remain to be investigated.
Organelles also talk to the nucleus through retrograde sig-
naling, but the nature of the underlying cascade that relays
the information is largely unknown (7–9) and mitochon-
drial regulation mechanisms as a whole are still elusive.
Mutations in the human organelle genome cause severe
neurodegenerative diseases that are currently incurable
(10). In plants, the mitochondrial genome is the source
of cytoplasmic male sterility (CMS), a trait of major inter-
est to crop breeders for hybrid generation (11). Genetic
interactions between the organelles and the nucleus were
reported to affect a number of other important agrono-
mical traits, including yield, heterosis, combining ability,
selﬁng rate, disease resistance and temperature or drought
tolerance (12–14). The mechanisms underlying these
cytoplasmically inherited effects are still largely unex-
plored and in many cases the respective roles of mitochon-
drial and chloroplastic genetics remain to be established.
Progress in the understanding of mitochondrial genetic
processes and regulation pathways, as well as development
of suitable gene technologies, are hindered by the lack of
molecular approaches to manipulate and control the
genetic system in these organelles. Chloroplast transform-
ation was established more than two decades ago, ﬁrst in
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subsequently in tobacco (Nicotiana tabacum) (16), based
on biolistic-mediated transfection and homologous recom-
bination of the transfected DNA with the resident plastid
DNA. Episomal maintenance was later demonstrated,
using a shuttle vector carrying a plastid origin of replica-
tion (17). Transplastomic plants have signiﬁcantly
contributed to the understanding of chloroplast gene ex-
pression, RNA editing or functional processes and the
strategy has now entered biotechnological applications
(18–21). In contrast, mitochondria are still amenable to
genetic transformation only in yeast and C. reinhardtii
(22,23). In this respect, we present here a major break-
through for organelle genetics.
In the last decade, RNA-based strategies have become
approaches of choice to silence eukaryotic genes and have
been quite successful. However, there has been no indica-
tion that RNA interference, or a similar mechanism,
would operate in organelles, as such pathways require a
complex endogenous machinery. On the other hand, cata-
lytic RNAs carry their own activity but they have to be
adapted to the expected cellular context. Both approaches
anyway need to target customized RNAs into the organ-
elles. As a critical progress, the present work answers two
of these questions. First, we have developed nuclear ex-
pression and organelle import of customized RNA se-
quences. In many organisms, including mammals, the
mitochondrial genome does not code for a complete set
of transfer RNAs (tRNAs), so that nuclear-encoded
tRNAs are taken up from the cytosol (24,25). The
process applies to one third to one half of the organelle
tRNAs in higher plants. We demonstrate here that ‘pas-
senger’ RNAs driven by a tRNA mimic can be trans-
located into mitochondria in plant cells. Second, we
have designed and functionally validated in vitro a com-
posite RNA bringing together a trans-cleaving ribozyme
and a tRNA-like structure (TLS). Subsequent expression
in plant cell suspensions and whole plants from a nuclear
transgene established that this chimeric catalytic RNA
was imported into the organelles and that the ribozyme
moiety was active inside mitochondria. Furthermore,
ribozyme-mediated cleavage triggered a drastic decrease
in the level of the target, leading to the ﬁrst directed
RNA knockdown in the mitochondria of a multicellular
eukaryote. Our results thus open new horizons for genetic
investigation and functional manipulation of these organ-
elles in living cells.
MATERIALS AND METHODS
Bioinformatic methods
The linker (L) to provide spacing between the hammer-
head and PKTLS motifs in the chimera was selected from
a pool of random sequences. The selection was based on
predictions of RNA secondary structures using MFOLD
(26). The candidate was chosen on the basis of its inability
to form stable structures that would interfere either with
PKTLS formation or hammerhead binding to the target
sequence.
Gene constructs
Primer sequences are given in Supplementary Data and
Supplementary Table S1. To generate a construct express-
ing the PSTY passenger sequence with the PKTLS tRNA
mimic and the cHDV cis-ribozyme, two successive PCR
reactions were carried out. The cHDV sequence was ﬁrst
ampliﬁed from a pre-existing recombinant plasmid (27)
with the TLS-HDV5P direct primer, carrying an extension
corresponding to the 30-end of the PKTLS, and the
HDV3PX reverse primer containing an XbaI site.
Together with the TLS5PB direct primer containing a
BamHI site, the resulting product served as a ‘mega-
primer’ in a second PCR reaction which used as a
template the pTYMC plasmid carrying the full TYMV
genomic sequence (28). The second PCR created a
fusion between the sequence of the last 186nt (positions
6134–6318) of the TYMV genome (accession number
X16378) and the sequence of the cHDV cis-ribozyme
(27). The obtained fragment was subsequently inserted
into the pCK-GFPS65C plasmid [i.e. the pRTL2 expres-
sion vector (29) containing the GFPS65C gene (30)]
between the BamHI and XbaI sites located 30 to the
GFP sequence, yielding the pCKGFPS65C-
PSTYPKTLScHDV plasmid. The latter was digested
with XhoI and BamHI, so as to eliminate the translation
leader and the GFP gene still present at that stage. The
sticky ends were ﬁlled with the Klenow fragment of
Escherichia coli DNA polymerase I and the DNA was
re-circularized. The resulting pCK-PSTYPKTLScHDV
plasmid was ﬁnally digested with HindIII and the
whole expression cassette (CaMV 35S promoter,
PSTYPKTLScHDV sequence, 35S terminator) was
cloned into the HindIII site of the binary vector pBI101
(Clontech), generating the pBI-PSTYPKTLScHDV
plasmid. The sequence differences in the PKTLSmet
mutated variant versus the original PKTLS are loc-
ated outside of the above primers. An identical
strategy was thus developed to generate the pBI-
PSTYPKTLSmetcHDV construct, taking in this case as
starting template the pTYMC-U55/C54/A53(L1=UU)
plasmid (31) which carries the TYMV cDNA with the
relevant mutations to confer a methionine speciﬁcity to
the PKTLS.
For the catalytic RNA strategy, the complete sequence
encoding the Rzatp9 trans-ribozyme, the linker L, the
PKTLS and the cHDV cis-ribozyme was assembled by
PCR ampliﬁcation from the pCK-PSTYPKTLScHDV
plasmid with the direct primer RzLTLS5PH containing
a HindIII site and the reverse primer HDV3PE containing
an EcoRI site. The obtained product was introduced into
the HindIII and EcoRI sites of the pUCAP vector (32),
re-excised with the AscI and PacI enzymes and ﬁnally
cloned into the AscI and PacI sites of the inducible tran-
scription unit of the pER8 vector (33), generating the
pER8-Rzatp9LPKTLScHDV plasmid.
Nuclear transformants
Plasmids encoding the passenger RNAs, PKTLS and
cHDV cis-ribozyme were used to transform Nicotiana
tabacum BY-2 cells via Agrobacterium tumefaciens
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were selected on solid medium with kanamycin (pBI de-
rivatives) or hygromycin (pER8 derivatives) and dispersed
in liquid medium to generate transformed cell suspensions.
For transgene expression, cells were subcultured in
estradiol-supplemented liquid medium.
Plasmids carrying the gene constructs served in turn to
transform Arabidopsis thaliana (Col-0) plants via A.
tumefaciens through ﬂoral dip (35). Seeds were collected
and germinated on solid agar medium containing
hygromycin for selection. Antibiotic-resistant plants were
grown further in the greenhouse to obtain next generation
seeds. Homozygous transformants were used for Rzatp9-
L-PKTLS RNA expression and atp9 mRNA knockdown
analysis. Plants were grown on solid agar medium which
was overlaid with estradiol-supplemented liquid medium
for transgene induction. Alternatively, plants grown on
solid agar were transferred to culture plates containing
liquid medium supplemented with estradiol and the
roots were dipped into the medium.
Isolation of mitochondria
Protoplasts derived from BY-2 cells were resuspended in
extraction buffer (0.3M sucrose, 30mM sodium diphos-
phate, 2mM EDTA, 0.3% w/v BSA, 0.8% w/v polyvinyl
pyrrolidone 25K, 0.05% w/v cysteine, 5mM glycine,
2mM b-mercaptoethanol, pH 7.5) and disrupted by
three passages through a 30-mm mesh nylon net (Scrynel,
ZBF, Ru ¨ schlikon, Switzerland). Mitochondria were
further isolated according to Delage et al. (36) using dis-
continuous Percoll (Sigma) gradients. Prior to RNA ex-
traction, puriﬁed organelles were incubated in buffer
containing 100mg/ml RNase A and 750U/ml RNase T1,
re-isolated on Percoll gradients and washed with buffer
containing 5mM EDTA and 5mM EGTA.
RNA extraction
Total RNA was extracted from N. tabacum cell suspen-
sions and A. thaliana plants following standard TRI
Reagent protocols (Molecular Research Center). To
prepare organelle RNA, RNase-treated mitochondria
(1–5mg protein) were resuspended in 200ml extraction
buffer (Tris–HCl 10mM pH 7.5, MgCl2 10mM, SDS
1% w/v). After 2min of vigorous shaking, the suspensions
were centrifuged for 10min at 10000g. The supernatant
was phenol extracted and nucleic acids were ethanol
precipitated. The DNA was ﬁnally eliminated through
several successive DNase treatments.
Reverse transcription, RT–PCR and CR–RT–PCR
Reverse transcription was carried out with SuperScript III
(Invitrogen) using 2pmol of a speciﬁc primer
(Supplementary Data and Supplementary Table S1) or
250ng of a random hexanucleotide mixture. Reactions
were stopped by 15min incubation at 70 C and the RT
samples served directly for standard or real-time PCR.
Standard RT–PCR products were analyzed on agarose
gels, cloned into pGEM-T easy (Promega) and sequenced.
Prior to circularized RNA RT–PCR (CR–RT–PCR),
the cap was removed with tobacco acid pyrophosphatase
(Epicentre Biotechnologies). After phenol extraction and
ethanol precipitation, RNA circularization was carried
out with T4 RNA ligase (Fermentas). Reverse transcrip-
tion through the junction between the 50- and 30-end of the
RNAs of interest was performed with a direct primer in
the PKTLS sequence. The cDNA was used as a template
for a ﬁrst PCR with the same primer and a primer in the
passenger sequence, which was followed by a nested PCR.
The ﬁnal products were cloned into pGEM-T easy and
sequenced.
Templates for in vitro synthesis of the atp9 target RNAs
and ribozyme chimeras
Primer sequences are given in Supplementary Data and
Supplementary Table S1. DNA fragments corresponding
to nucleotides 31–130 of the A. thaliana atp9-coding
sequence (positions 278895–279152 in the complete mito-
chondrial genome with the accession number Y08501), or
nucleotides 15–160 of the N. tabacum atp9-coding
sequence (nucleotides 145758–145991 in the complete
mitochondrial genome with the accession number NC_
006581) were PCR ampliﬁed from A. thaliana or
N. tabacum DNA using the primer pairs Atcibatps/
Atcibatpas and Ntcibatps/Ntcibatpas, respectively. The
direct primers contained the T7 RNA polymerase
promoter. The DNA template for the synthesis of the
Rzatp9-L-PKTLS RNA was constructed through two
successive PCR steps. The ﬁrst reaction was run with
the primer pair linatps/TLS3P using the pCK-
PSTYPKTLScHDV plasmid as a template. This step
allowed joining the linker sequence to the PKTLS. The
product of the ﬁrst PCR was used as a template for
a second ampliﬁcation with the primer pair rzatps/
TLS3P, joining the T7 promoter and ribozyme sequence
to the linker already attached to the PKTLS. The DNA
template for the synthesis of the extRzatp9-L-PKTLS
RNA was ampliﬁed in a single PCR step with
the primer pair ext5P/TLS3P taking the pER8-
Rzatp9LPKTLScHDV plasmid as a template. The direct
primer ext5P was carrying the T7 promoter sequence.
Final PCR products to be used as templates for transcrip-
tion were puriﬁed on Sephadex G-50 spin columns.
In vitro ribozyme cleavage assays
The atp9 target RNAs and ribozyme chimeras were syn-
thesized in vitro from the PCR constructs with T7 RNA
polymerase and a RiboMAX kit (Promega). Radiolabeled
target RNAs were obtained by including [a-
32P]UTP
(800Ci/mmol) into the reaction medium. Following tran-
scription, DNA templates were hydrolyzed with RNase-
free DNase (1U, 15min at 37 C). Transcripts were
puriﬁed by phenol and chloroform extraction, gel-ﬁltered
on Sephadex G-50 spin columns and quantiﬁed by UV-
absorbance measurement. The Rzatp9 RNA comprising
only the trans-ribozyme was from Eurogentec.
Cleavage reactions containing 15nM of unlabeled target
RNA, 50fmol (30000 cpm) of labeled target RNA,
150nM of ribozyme or ribozyme-L-PKTLS chimera, in
50mM Tris–HCl pH 7.5 were incubated at 25 C for
1–5h. Prior to the cleavage reaction, the target RNA
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75 C and slowly cooled down to 25 C to release the
RNA structures resulting from the fast T7 RNA polymer-
ase in vitro transcription. Cleavage products were fract-
ionated on denaturing polyacrylamide gels and
visualized by autoradiography.
Real-time PCR
Real-time PCR reactions were run on an iCycler
(BioRad). Primers (Supplementary Data and
Supplementary Table S1) were designed with the
PrimerExpress software (Applied Biosystems). Their efﬁ-
ciency was veriﬁed with the LinRegPCR software (37)
(bioinfo@amc.uva.nl). Real-time PCR was carried out
in 20ml samples containing 10ml SybrGreen kit
(MasterMix Plus, Eurogentec), 0.6mM direct and reverse
primer and 1ml RT reaction (performed with a random
hexanucleotide mixture). The following steps were
applied: one cycle at 95 C for 30s; one cycle at 50 C for
2min and 95 C for 10min; 40 cycles at 95 C for 1min and
60 C for 1min; one cycle at 95 C for 1min and 55 C for
1min; ﬁnally 80 cycles from 55 to 94.5 C, with a 0.5 C
increment every 10s to obtain a melting curve. Results
were analyzed with the iQ5 software (BioRad). The
nuclear gene encoding actin (accession AB158612) and
the mitochondrial gene encoding RPL2 (accession
BA000042, region 361051–363948) showed the most
stable expression in our assays according to geNorm
(38) and were taken as reference genes with the couples
of primers ACTIN-1FW/ACTIN-1RV and RPL2-1FW/
RPL2-1RV (Supplementary Data and Supplementary
Table S1).
FLOE and 50-RACE
Primer sequences are given in Supplementary Data and
Supplementary Table S1. For ﬂuorescently labeled oligo-
nucleotide extension [FLOE (39)], 5mg of mitochondrial
RNA were used for extended SuperScript III reverse tran-
scription with 5nmol of the atp9tot3P-ROX reverse
primer labeled at the 50-end with 6-carboxy-X-rhodamine
(ROX). After RNase A digestion, the cDNAs were
ethanol precipitated, redissolved in water and completed
with 8ml of 1000 times diluted GeneScan 500 ROX ﬂuor-
escent size standard (Applied Biosystems). Samples were
ﬁnally analyzed with a capillary electrophoresis sequencer
(Applied Biosystems).
50-Rapid ampliﬁcation of cDNA ends (50-RACE) was
carried out with the GeneRacer kit (Invitrogen). After
ligation with the provided RNA primer, reverse transcrip-
tion was run with SuperScript III and the atp9tot3P
reverse primer. The ﬁnal PCR involved the same primer
and the Generacer5P direct primer corresponding to the
sequence added through ligation. PCR products were
analyzed on agarose gels, cloned into the pCR2.1-TOPO
vector (Invitrogen) and sequenced.
Further RNA analyses
RNase protection was run according to Goodall et al.
(40). [
32P]-labeled antisense probes and unlabeled sense
transcripts were synthesized in vitro from appropriate
templates with T7 RNA polymerase and a RiboMAX
kit (Promega). Antisense hybridization was run overnight.
Final products after RNase digestion were fractionated on
denaturing polyacrylamide gels and visualized by auto-
radiography. Northern blot analyses were carried out fol-
lowing standard protocols with digoxigenin-labeled
probes (Roche).
In organello protein synthesis
Mitochondria corresponding to 100mg protein were
incubated for 1h at 25 C in 100ml of IS buffer (5mM
KH2PO4, 300mM mannitol, 60mM KCl, 50mM
HEPES pH 7.0, 10mM MgCl2, 10mM sodium malate,
10mM NADH) completed with 2mM GTP, 4mM
ADP, 2mM DTT, 0.1% w/v BSA, 25mM of each amino
acid except methionine and 20–50mCi [
35S]methionine
(>800Ci/mmol). The reactions were stopped upon add-
ition of 1ml washing buffer (300mM sucrose, 10mM
K2HPO4, 1mM EDTA, 5mM glycine, 0.1% w/v BSA,
pH 7.5) containing 10mM unlabeled methionine. The
samples were then centrifuged for 5min at 12000g to
collect the organelles. Final mitochondrial pellets were
analyzed by SDS polyacrylamide gel electrophoresis
(SDS–PAGE) and ﬂuorography according to standard
protocols.
RESULTS
A mitochondrial translocation vector
We showed earlier that a bean (Phaseolus vulgaris)
tRNA
Leu expressed from a nuclear transgene and carrying
a 4-bp insertion in the anticodon loop was recovered in the
mitochondria of transformed potato (Solanum tuberosum)
plants (41). However, insertion of longer sequences was
not successful. Grafting the ‘passenger’ RNA to the
50-end of the tRNA
Leu as a trailor sequence also failed,
due to RNase P removal of the extra sequence. We thus
developed the use of a tRNA mimic as a mitochondrial
import vector and selected the TLS formed by the last
82nt at the 30-end of the Turnip yellow mosaic virus
(TYMV) genomic RNA (42). Mitochondrially imported
tRNAs in higher plants include valine isoacceptors (43)
and the TYMV TLS (Figure 1a) is an efﬁcient tRNA
Val
mimic. Its sequence does not comply with the consensus
RNA polymerase III internal promoters, making easy a
polymerase II-driven expression, and it does not seem to
be processed by RNase P in plant cells. Finally, using an
in vitro system (44), we showed that the TYMV TLS can
be imported into isolated plant mitochondria with an ef-
ﬁciency and an ATP-dependence similar to those of a
regular tRNA (Supplementary Data and Supplementary
Figure S1). A pseudoknot (UPSK) upstream of the TLS in
the TYMV genomic RNA contributes to optimized
function in 30 translational enhancement, which is depend-
ent on aminoacylation (42); mitochondrial import of
tRNAs in plant cells likewise seems to depend on inter-
action with the aminoacyl-tRNA synthetase (36,45). Thus,
the tRNA mimic taken as a mitochondrial translocation
vector consisted of the last 120nt from the 30-end of the
Nucleic Acids Research, 2011,Vol.39, No. 21 9265TYMV genomic RNA, including the TLS and the UPSK.
This sequence will be called ‘PKTLS’ (Figure 1a).
Mitochondrial import of trailor RNAs
The strategy we developed for nuclear expression and
mitochondrial import of RNAs of interest in plant cells
is summarized in Figure 2. Plant cells are nuclearly trans-
formed with constructs encoding a passenger sequence
attached to the 50-end of the TYMV PKTLS. These se-
quences are under the control of an RNA polymerase II
promoter (constitutive or inducible) and terminator,
yielding polyadenylated transcripts. To generate RNAs
with the aminoacylatable TYMV TLS at the 30-end, the
sequence encoding the cis-cleaving ribozyme of the
Hepatitis delta virus (cHDV) (27) is inserted into the con-
structs between the TYMV PKTLS cDNA and the ter-
minator. Expression of the nuclear transgene thus
generates a 50-capped transcript comprising, successively,
the passenger RNA, the PKTLS, the cHDV and the
poly(A) tail. Self-cleavage of the cHDV eliminates the
poly(A) tail and releases the regular 30-CCA end of
the PKTLS. The passenger RNA associated with the
PKTLS is then exported from the nucleus to the cytosol,
presumably recognized by the mitochondrial tRNA
import machinery and ﬁnally imported into the organelles.
We ﬁrst took as a passenger sequence the 66nt located
immediately upstream (positions 6134–6199) of the
PKTLS (positions 6200–6318, plus a 30-A) in the TYMV
genomic RNA (Figure 1a, PSTY). The expected function-
ality of the PSTY-PKTLS RNA was assessed by establish-
ing the capacity of the corresponding in vitro-synthesized
transcript to be aminoacylated with valine in the presence
of enzymatic extracts from N. tabacum BY-2 cell sus-
pensions (Supplementary Data and Supplementary
Figure S2a). According to the above strategy (Figure 2),
the sequences encoding the PSTY passenger, the PKTLS
translocation vector and the cHDV were assembled under
the control of the CaMV 35S promoter in the pBI101
plasmid. The construct was used for nuclear transform-
ation of N. tabacum BY-2 cells.
Total and mitochondrial RNAs were prepared from
transformant cells harvested at mid-exponential growth
phase. RT–PCR with the corresponding primers showed
the presence of the PSTY-PKTLS RNA in the total
RNA fraction and in the mitochondrial RNA fraction
(Figure 1b, lanes 1 and 5). The identity of the RT–PCR
products was conﬁrmed by cloning and sequencing.
Control reactions assessed the speciﬁcity of the ampliﬁca-
tions and the absence of signiﬁcant cytosolic contamin-
ation of the mitochondrial fractions. Self-cleavage of the
cHDV was demonstrated by the absence of ampliﬁcation
products in reactions involving the corresponding reverse
primer (Figure 1b, lanes 2 and 6). Accuracy of cHDV
self-cleavage was conﬁrmed by CR–RT–PCR, with
Figure 1. Mitochondrial import of a nuclear transgene-encoded pas-
senger sequence in N. tabacum cells. (a) The PSTY-PKTLS RNA
used to validate in vivo mitochondrial translocation. The PSTY passen-
ger sequence, with six additional nucleotides (underlined and in italics)
transcribed from the pBI-PSTYPKTLScHDV plasmid (see ‘Materials
and Methods’ section), is attached to the 50-end of the PKTLS
composed of the TLS and upstream pseudoknot (UPSK). Base pairs
forming pseudoknots are shown as dashed lines. (b) RT–PCR assays
carried out with total or mitochondrial (Mito) RNA from transgenic
N. tabacum cells expressing the PSTY-PKTLS-cHDV RNA. cDNA was
synthesized with a reverse primer designed to amplify either the PSTY-
PKTLS sequence (TLS3P) or the complete PSTY-PKTLS-cHDV
sequence (HDV3P), in case self-cleavage of the cHDV would not
have occurred. Subsequent PCR was run with primer TLS3P or
HDV3P and a direct primer corresponding to the 50-end of PSTY
(PS5P). Ampliﬁcation of the cytosolic tRNAs
Pro (Cyto tRNAPro)
with primers PRO5P and PRO3P served as a contamination control
for the mitochondrial fraction. Primers CYS5P and CYS3P for mito-
chondrial tRNA
Cys (GCA) (Mito tRNACys) were used to conﬁrm the
identity of the mitochondrial fraction. (c) RNase protection assays
carried out with total or mitochondrial RNA from transgenic
N. tabacum cells expressing the PSTY-PKTLS-cHDV RNA using
in vitro synthesized antisense probes for PKTLS or cytosolic
tRNAs
Pro. RNA preparations from non-transformed cells served as
Figure 1. Continued
controls. Assays with in vitro-synthesized sense transcripts (lanes 15 and
16) yielded reference products. Marker sizes are indicated in kilobases
(kb) or nucleotide numbers (nt). Primer sequences are given in
Supplementary Data and Supplementary Table S1.
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Total and mitochondrial RNA fractions from trans-
formed cells were further analyzed through RNase protec-
tion assays using a radioactive probe complementary to
the PKTLS. The results showed the protection of an anti-
sense fragment of the expected size in the presence of
either the total or the mitochondrial RNA fraction
(Figure 1c, lanes 9 and 12). No fragment was protected
in the presence of RNA fractions from untransformed
cells (Figure 1c, lanes 10 and 13). Assays with a radio-
active probe complementary to cytosol-speciﬁc tRNA
Pro
again conﬁrmed the absence of signiﬁcant cytosolic con-
tamination of the mitochondrial fractions (Figure 1c, lane
14). These experiments established that the PKTLS tRNA
mimic was able to drive passenger RNAs into
mitochondria.
Mitochondrial translocation and tRNA import speciﬁcity
The TYMV PKTLS mimics tRNA valine, a tRNA which
is naturally imported into mitochondria in plant cells. To
investigate whether the PSTY-PKTLS RNA was tran-
slocated into the organelles following the regular tRNA
import pathway, we changed the aminoacylation speciﬁ-
city. Cytosolic tRNA
Met is not taken up by mitochondria
in plant cells (43). In previous experiments (36), variants
of an Arabidopsis thaliana cytosolic tRNA
Val carrying
various mutations were expressed in tobacco cells from
transgenes. In line with the absence of cytosolic
tRNA
Met in the natural set of organelle tRNAs, a
mutant tRNA
Val possessing a methionine anticodon that
switches the aminoacylation speciﬁcity from valine to me-
thionine was not recovered in mitochondria (36).
A mutated TYMV TLS variant accepting methionine
instead of valine was described previously (31). Based on
these data, we designed PKTLSmet (Figure 3a) mimicking
both a tRNA which is not naturally imported into plant
mitochondria and the above-mentioned tRNA
Val mutant.
PKTLSmet was in turn combined with the PSTY passen-
ger sequence and expressed in N. tabacum cells following
the strategy outlined in Figure 2. RT–PCR and RNase
protection analyses (Figure 3b) showed the presence of
the PSTY-PKTLSmet RNA in total RNA fractions
from the transformants but not in mitochondrial RNA
fractions (Figure 3b, lanes 1 and 4). Thus, the PSTY-
PKTLSmet RNA was expressed but not imported into
mitochondria. Aminoacylation assays showed that the
in vitro-synthesized PSTY-PKTLSmet transcript had
indeed lost the capacity to be valylated but could be
charged with methionine (Supplementary Data and
Supplementary Figure S2c). The lack of mitochondrial
import of PSTY-PKTLSmet in the transformed cells was
thus unlikely to be due to a lack of functionality of the
RNA but, like in the case of the mutant tRNA
Val, rather
reﬂected the change in amino acid speciﬁcity. Altogether,
the data indicated that PKTLS-driven mitochondrial
Figure 2. General scheme of the strategy developed for nuclear expression and mitochondrial import of RNAs of interest in plant cells. Description
of the different steps is given in the text.
Nucleic Acids Research, 2011,Vol.39, No. 21 9267translocation followed the natural tRNA import speciﬁ-
city, suggesting a transport along the regular tRNA
uptake pathway.
A chimeric trans-cleaving ribozyme
Demonstrating the ﬂexibility of mitochondrial RNA
translocation opened the way for functional and genetic
manipulation of mitochondria in plant cells. As a further
breakthrough, we developed speciﬁc knockdown of target
RNAs in mitochondria, using as a passenger sequence of
the PKTLS a trans-cleaving catalytic RNA, i.e. a hammer-
head ribozyme. The atp9 mRNA was chosen as a target.
Knockdown of this major mitochondrial mRNA was of
interest both to establish the efﬁciency of the approach
and to initiate regulation studies. The main obstacle
in applying hammerhead ribozymes in vivo is their re-
quirement for much higher free magnesium concentrations
(10–25mM) than those estimated to be present in cells
[1–2mM in plant mitochondria (46)]. We designed the
trans-cleaving hammerhead ribozyme against the atp9
mRNA (Rzatp9, Figure 4a) based on a shortened catalytic
core derived from the results of in vitro selection for vari-
ants active in low magnesium conditions (47). Such ribo-
zymes, with 2 instead of 4bp in helix II and a UUUU
tetraloop, showed high activity at very low Mg
2+ concen-
tration both in vitro and in vivo (48). The targeted site
contained an AUC triplet, which is efﬁciently cleaved if
placed in an appropriate sequence context (49). To ensure
high speciﬁcity of the ribozyme, the antisense ﬂanks
responsible for target recognition and binding were
designed to form 8 and 7bp in helixes I and III, respect-
ively (Figure 4a). The Rzatp9 ribozyme was attached to
the 50-end of the PKTLS through a speciﬁc 42-nt linker
(L), to provide spacing and avoid alternative structures.
The functionality of the PKTLS in the chimeric RNA was
in turn assessed by establishing the capacity of the corres-
ponding in vitro-synthesized transcript to be aminoacy-
lated with valine in the presence of enzymatic extracts
from N. tabacum BY-2 cell suspensions (Supplementary
Data and Supplementary Figure S2b).
In vitro ribozyme cleavage activity
The catalytic activity of the Rzatp9 ribozyme alone or
included in a T7 RNA polymerase-synthesized
Rzatp9-L-PKTLS RNA was ﬁrst assayed in vitro at vari-
ous magnesium concentrations. A 100-nt long RNA cor-
responding to part of the A. thaliana atp9 mRNA was
used as a substrate (Figure 4b). Both Rzatp9 and
Rzatp9-L-PKTLS ribozymes efﬁciently cleaved the target
RNA at submillimolar Mg
2+ concentrations (Figure 4c).
Hydrolysis occurred at Mg
2+ concentrations as low as
0.1mM (Figure 4c, lane 8). Preparing the in vivo
strategy, the activity of an extended Rzatp9-L-PKTLS
RNA (extRzatp9-L-PKTLS, 50-extension of 40nt), repre-
sentative for the full transcript expected upon expression
from the pER8 vector [(33), see below], was assayed
in vitro with a 146-nt-long target derived from N.
tabacum atp9 (Figure 4d and e). Again, an efﬁcient
cleavage was observed, even in the absence of added
Mg
2+ in the assay (Figure 4e, lane 17). Thus, a properly
devised ribozyme/linker/PKTLS chimera retains high
catalytic activity at physiological magnesium concentra-
tions. Interestingly, additional sequences at both the 30
and the 50-end of the minimal Rzatp9 ribozyme not only
did not reduce its catalytic activity, but seemed to enhance
cleavage at low magnesium (Figure 4c and e).
Knockdown of a mitochondrial RNA in plant cells
The Rzatp9-, L-, PKTLS- and cHDV-encoding sequences
were subsequently assembled under the control of the
OLexA-46 estradiol-inducible promoter in the pER8
vector (33) and used for nuclear transformation of
N. tabacum BY-2 cells. Total and mitochondrial RNAs
from induced transformant cells harvested at Day 4 after
onset of estradiol treatment were tested as above by
RT–PCR and RNase protection, demonstrating the
expression and efﬁcient mitochondrial import of the
Figure 3. Mitochondrial import speciﬁcity of nuclear transgene-
encoded passenger sequences in N. tabacum cells. (a) The
PSTY-PKTLSmet RNA used to test the speciﬁcity of in vivo mitochon-
drial translocation. The structure is as in Figure 1a but the TLS moiety
carries a methionine anticodon, two further nucleotide exchanges in the
anticodon loop and 2nt deletions in the L1 loop (bold on white back-
ground). (b) RNase protection assays carried out with total or mito-
chondrial RNA from transgenic N. tabacum cells expressing the
PSTY-PKTLSmet-cHDV RNA using in vitro synthesized antisense
probes for PKTLSmet or cytosolic tRNAs
Pro (contamination
control). RNA preparations from non-transformed cells served as
controls. Assays with in vitro-synthesized sense transcripts (lanes 7
and 8) yielded reference products. Marker sizes are indicated in nucleo-
tide numbers (nt).
9268 Nucleic Acids Research, 2011,Vol.39, No. 21Figure 4. Structure and in vitro trans-cleaving activity of the Rzatp9-L-PKTLS chimeric RNA. (a) Structure of the Rzatp9-L-PKTLS RNA. The
trans-cleaving ribozyme Rzatp9 directed against the atp9 mRNA is attached to the 50-end of the PKTLS via a 42-nt linker (L) selected from a pool of
random sequences. The Rzatp9 hammerhead sequence is annealed to the target sequence motif in the atp9 mRNA. The cleavage site is indicated by a
black triangle. (b) Position of the target sequence (At in vitro target) used in (c) and of the Rzatp9 cleavage site in the A. thaliana atp9-coding
sequence. (c) Trans-cleaving activity of the Rzatp9 hammerhead ribozyme alone and of the Rzatp9-L-PKTLS RNA as a function of Mg
2+ concen-
tration. A [
32P]-labeled target transcript derived from the A. thaliana atp9-coding sequence as indicated in (b) was incubated with in vitro synthesized
Rzatp9 (lanes 2–6) or Rzatp9-L-PKTLS (lanes 7–11). Reactions were run for 2h in standard conditions (see ‘Materials and Methods’ section). The
ribozyme/target molar ratio was 10/1. (d) Position of the target sequence (Nt in vitro target) used in (e) and of the Rzatp9 cleavage site in the
N. tabacum atp9-coding sequence. (e) Trans-cleaving activity of the Rzatp9 ribozyme alone and of the 50-extended Rzatp9-L-PKTLS RNA ex-
pected from in vivo expression (extRzatp9-L-PKTLS) as a function of Mg
2+ concentration. A [
32P]-labeled target transcript derived from the
N. tabacum atp9-coding sequence as indicated in (d) was incubated with in vitro synthesized Rzatp9 (lanes 14–16) or extRzatp9-L-PKTLS
(lanes 17–19). Reactions were run as in (c) for 3h. Migration of the full-length targets and of the fragments generated upon cleavage is indicated
by arrows.
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the chimeric ribozyme in estradiol-induced transformed
cells was subsequently analyzed by real-time RT–PCR
over a 1-week growth cycle. The Rzatp9-L-PKTLS level
reached a plateau from Day 3 to Day 5 and decreased
when approaching the stationary phase (Figure 6a). The
same samples served in turn as real-time RT–PCR tem-
plates to assess the levels of the atp9 mRNA. Control
levels were established with RNA samples from uninduced
transformed cells and from estradiol-treated wild-type
cells. Estradiol showed a signiﬁcant effect on RNA levels
in wild-type cells. Accurate analysis was thus carried out
by comparing the atp9 mRNA levels in RNA samples
from estradiol-treated transformant cells and estradiol-
treated wild-type cells. We demonstrated that, after a lag
phase, the atp9 mRNA level dropped by 80% at Day 4 in
induced transformant cells versus estradiol-treated wild-
type cells (Figure 6b). Mitochondria isolated at Day 4
from uninduced and estradiol-induced transformant cells
were used in turn for in organello translation assays in the
presence of [
35S]methionine. Reﬂecting the drop in the
Figure 6. Expression of the Rzatp9-L-PKTLS RNA and target
knockdown in cell cultures. (a) Relative expression of the
Rzatp9-L-PKTLS RNA in N. tabacum cells transformed via the
pER8-Rzatp9LPKTLScHDV plasmid (see ‘Materials and Methods’
section) and treated with estradiol. Cells were harvested every day
over a 1-week culture period. Estradiol was added to the medium at
the beginning of the culture. Total RNA was prepared from all samples
and cDNA was synthesized with a random hexanucleotide mixture. The
cDNA served as a template for real-time PCR analysis with the direct
primer RZATP9-TLS-FW speciﬁc for Rzatp9 and the reverse primer
RZATP9-TLS-RV speciﬁc for the PKTLS (Supplementary Data and
Supplementary Table S1). (b) Relative level of the atp9 mRNA in N.
tabacum cells transformed via pER8-Rzatp9LPKTLScHDV and treated
with estradiol. The cDNA samples from (a) served in turn as templates
for real-time PCR analysis with primers ATP9-1-66NT-FW and
ATP9-1-66NT-RV (Supplementary Data and Supplementary Table
S1) speciﬁc for the atp9 sequence. (c) In organello protein synthesis
with [
35S]methionine in mitochondria isolated from N. tabacum cells
transformed via pER8-Rzatp9LPKTLScHDV, untreated or treated
with estradiol and harvested at Day 4. Migration of ATP9, as estab-
lished with puriﬁed protein obtained through chloroform/methanol ex-
traction, is indicated by an arrow.
Figure 5. Mitochondrial import of the Rzatp9-L-PKTLS chimeric
RNA in cell cultures. (a) RT–PCR assays carried out with total or
mitochondrial (Mito) RNA prepared from N. tabacum cells trans-
formed via pER8-Rzatp9LPKTLScHDV (see ‘Materials and
Methods’ section), treated with estradiol and harvested at Day 4.
cDNA was synthesized with the reverse primer TLS3P complementary
to the 30-end of PKTLS. Subsequent PCR was run with the direct
primer Rzatp95P corresponding to the 50-end of Rzatp9 and the
reverse primer TLSmP complementary to an internal sequence close
to the 30-end of PKTLS (Supplementary Data and Supplementary
Table S1). Ampliﬁcation of cytosolic tRNAs
Pro (Cyto tRNAPro, con-
tamination control) and mitochondrial tRNA
Cys(GCA) (Mito
tRNACys, identity of the mitochondrial fraction) were as in
Figure 1b. (b) RNase protection assays carried out with total or mito-
chondrial RNA from N. tabacum cells transformed via pER8-
Rzatp9LPKTLScHDV, treated with estradiol and harvested at Day
4. In vitro synthesized antisense probes for PKTLS or cytosolic
tRNAs
Pro were used. RNA preparations from non-transformed cells
served as controls. Assays with in vitro synthesized sense transcripts
(lanes 13 and 14) yielded reference products. Marker sizes are indicated
in kilobases (kb) or nucleotide numbers (nt).
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reduced by  40% in mitochondria from induced trans-
formant cells (Figure 6c). Only translation of the ATP9
protein was affected, underlining the speciﬁcity of the
process. The absence of non-speciﬁc effects was further
supported by proteomic analyses (Supplementary Data
and Supplementary Figure S3). Observations from in
organello translation assays also conﬁrmed that the atp9
mRNA was knocked down inside the organelles.
That the drop in atp9 mRNA level resulted from
ribozyme cleavage was shown by ﬂuorescently labeled
oligonucleotide extension [FLOE (39)] and 50-RACE-
PCR. FLOE assays with a 30 primer and mitochondrial
RNA samples from uninduced transformed cells harvested
after 4 days of subculturing detected a 357-nt precursor of
the atp9 mRNA and a 244-nt mature form (Figure 7a and
b). Levels of these products were reduced when analyzing
mitochondrial RNA samples from estradiol-treated trans-
formed cells harvested at the same stage, and a new signal
appeared corresponding to the 168-nt 30 fragment expected
upon ribozyme cleavage of the atp9 mRNA (Figure 7a
and c). This fragment was speciﬁc for mitochondrial
RNA from induced transformant cells. A minor primer
extension product of only 133nt was also detected in the
FLOE pattern from cells expressing the Rzatp9-L-PKTLS
RNA (Figure 7c). The atp9 sequence at that distance from
the 30 end offers no possibility for ribozyme annealing and
cleavage. The 133-nt fragment might thus represent some
secondary intermediate generated by the mitochondrial
RNA degradation system following the initial cleavage
mediated by the imported chimeric ribozyme. 50-RACE–
PCR assays involving the same 30 primer also detected the
168-nt fragment, as well as the fragments representative
for the precursor and processed atp9 mRNA. Cloning/
sequencing conﬁrmed the identity of all products.
Worthy to notice, RNA samples from induced trans-
formant cells at Day 3 already contained highest levels
of Rzatp9-L-PKTLS but retained normal atp9 mRNA
levels (Figure 6a and b). This further excluded that the
atp9 drop observed with samples from Days 4 and 5 be
due to target cleavage during RNA extraction and
handling. Thus, the results altogether demonstrated that
the Rzatp9-L-PKTLS chimeric ribozyme expressed from a
nuclear transgene was imported into mitochondria and
speciﬁcally cleaved its target RNA at the expected pos-
ition, triggering a strong knockdown. These observations
establish that appropriate trans-cleaving ribozymes are
active in the organelles.
Mitochondrial RNA knockdown in whole plants
The pER8 plasmid carrying the Rzatp9-L-PKTLS-cHDV
construct was used in turn to generate stable A. thaliana
transgenic plants. When the expression of the Rzatp9-
L-PKTLS RNA was induced in fully developed plants
(Figure 8a) cultivated under long day conditions (16h
light/8h dark), the atp9 mRNA dropped to a very low
level, as revealed by northern blot analysis (Figure 8b).
The knockdown persisted when the induction was main-
tained through regular estradiol treatment. No dramatic
change in phenotype was observed over a period of
12 days, suggesting that in such a context where the re-
quirement for mitochondrial activity is moderate, the turn-
over of the ATP9 protein is slow and the atp9 mRNA in
excess. Nevertheless, also in younger plants (Figure 8c)
maintained in short day conditions (8h light/16h dark)
induced expression of the Rzatp9-L-PKTLS RNA led to
a strong and persistent atp9 knockdown (Figure 8d). On
the other hand, expressing the Rzatp9-L-PKTLS RNA in
very young plantlets (Figure 8e) grown under short day
conditions yielded transient atp9 knockdown (Figure 8f).
The latter observation suggests that, when the demand for
mitochondrial activity is high, the drop in atp9 level can be
sensed and possibly trigger increased synthesis. It can be
noticed that also in exponentially growing N. tabacum
cells, atp9 knockdown is partially released at Day 5,
Figure 7. In vivo cleavage of the mitochondrial atp9 mRNA. (a)
Scheme illustrating the products expected from ﬂuorescently labeled
oligonucleotide extension (FLOE, see ‘Materials and Methods’
section) of the atp9 precursor (357nt), mature form (244nt) and 30
fragment upon ribozyme cleavage (168nt), using the atp9tot3P-ROX
primer (Supplementary Data and Supplementary Table S1). Sizes of the
precursor and mature form were established by FLOE experiments with
RNA from wild-type N. tabacum cells and proved consistent with the
atp9 promoter data in Solanum tuberosum (62). (b) and (c) atp9 FLOE
analysis of total RNA from N. tabacum cells transformed via the
pER8-Rzatp9LPKTLScHDV plasmid (see ‘Materials and Methods’
section), untreated (b) or treated with estradiol (c) and harvested at
Day 4. The expected FLOE product representative for the 168-nt 30
fragment resulting from ribozyme cleavage is indicated by an arrow.
Nucleic Acids Research, 2011,Vol.39, No. 21 9271although the ribozyme is still at a high level (Figure 6a and
b). Whereas it is currently considered that organelle gene
expression is mostly constitutive, such observations are in
favor of mRNA control mechanisms in mitochondria with
relation to the plant developmental stage and culture con-
ditions. Knockdown of other organelle RNAs with specif-
ically designed trans-cleaving ribozymes will allow further
analysis of these processes. As a whole, the data demon-
strate that our molecular approach is extremely efﬁcient to
knockdown mitochondrial RNAs in whole plants and has
an important potential for the investigation of organelle
regulation mechanisms.
DISCUSSION
The molecular strategy developed in this work brings a
decisive breakthrough in the analysis and manipulation
of mitochondrial genetic processes. So far, investigations
on mitochondrial transcription, RNA processing, RNA
stability and degradation or RNA editing had to rely
mostly on reconstituted in vitro or in organello assays.
Allowing the import of customized sense or antisense
RNAs into the organelles, our results open the way for
direct in vivo analyses. Around half of the sequences in
plant mitochondrial genomes are of unknown origin and
function (3). Unexpectedly, most of these sequences are
transcribed (5). Trans-ribozyme-mediated knockdown of
such transcripts will uncover new functional and/or regu-
latory properties of plant mitochondria. In particular, it
will be of interest to look for putative RNA-mediated
regulation mechanisms in organelles, as candidate non-
coding RNAs have been identiﬁed in both mitochondria
and chloroplasts (50–52).
Our chimeric hammerhead ribozyme variant was
designed with a shorter core domain which differed from
the natural hammerhead motif contained in the satellite
RNA of Tobacco ringspot virus (53) in the length of helix
II (2bp instead of 4) and in the sequence of loop 2
(UUUU instead of GUGA) (Figure 4a), a structure pre-
viously shown to support in vitro activity at low magne-
sium concentration (47). This design indeed allowed a
drastic drop of the target mRNA level in mitochondria,
raising further interest for the use of trans-cleaving cata-
lytic RNAs in vivo. Differing from this minimal concept, it
has been demonstrated that sequence elements outside of
the core structure of natural hammerhead ribozymes
enable catalytic activity at physiological Mg
2+ concentra-
tions by facilitating and stabilizing the active conform-
ation via tertiary interactions between terminal loops or
internal bulges (54–56). Artiﬁcial tertiary stabilizing
motifs (TSMs) supporting ribozyme trans-cleavage in sub-
millimolar MgCl2 were also identiﬁed through SELEX
screening (57) and the observations were extended to dif-
ferent types of hammerhead ribozymes (58). In the present
study, we favored the short core minimal concept with the
view that it would be a better suited passenger RNA for
mitochondrial import and would be less prone to generate
structural conﬂicts with the PKTLS. Tertiary-stabilized
ribozymes can be an alternative but the longer loop and
the extended ﬂank enabling the formation of a bulge upon
annealing to the target RNA in turn enhance structural
constraints, so that combination with the PKTLS might
be more complex and affect mitochondrial import. On the
other hand, it can be noted that the efﬁciency of the
Figure 8. Expression of the Rzatp9-L-PKTLS RNA and target
knockdown in A. thaliana plants stably transformed via the pER8-
Rzatp9LPKTLScHDV plasmid (see ‘Materials and Methods’ section).
Mature plants cultivated under long day conditions (16h light/8h dark)
(a), developing plants cultivated under short day conditions (8h light/
16h dark) (c) and very young plantlets cultivated under short day con-
ditions (e) were treated with estradiol for various times to induce and
maintain the expression of the transgene (Rzatp9). Fresh estradiol-
containing medium was added every 3–4 days. Plants were harvested
at different time points and total RNA was extracted from all samples.
The expression of the Rzatp9-L-PKTLS RNA and the atp9 mRNA
level were analyzed by northern blotting (b, d and f). The 18S rRNA
served as a control. Migration of size marker RNAs is indicated. The
following couples of primers (Supplementary Data and Supplementary
Table S1) were used to amplify the probes: ext5Pnor and TLS3P (probe
for the Rzatp9-L-PKTLS RNA), atp9nor5P and atp9nor3P (probe for
the atp9 mRNA), 18Snor5P and 18Snor3P (probe for the 18S rRNA).
9272 Nucleic Acids Research, 2011,Vol.39, No. 21minimal ribozyme used here was not affected by the add-
itional 50 sequence generated from the in vivo transcription
unit or by the presence of the linker and PKTLS at the
30-end, rather the presence of these sequences could con-
tribute to increased RNA stability in the cells.
Properly designed hammerhead ribozymes are highly
speciﬁc and off-target effects are considered as rare (59).
To ensure speciﬁcity, the design of our ribozyme was
elaborated according to previous functional data. It is
known that the activity is signiﬁcantly reduced if there
are <14bp between the ribozyme and the target RNA,
whereas mismatches can be tolerated if the length of the
complementary region is 18bp or more (60). Increasing
the length of the base-paired regions ﬂanking the
cleavage site beyond an optimal threshold was thus not
considered as a factor improving speciﬁcity (61). The
target-annealing arms in our ribozyme design provide a
total of 15bp (8+7). According to the available data, this
ensures high speciﬁcity, as any mismatch will lead to a
drop in activity and the probability of an alternative, per-
fectly matching sequence is extremely low. In particular,
the ribozyme targeted against the atp9 mRNA has no al-
ternative candidate cleavage site in the whole N. tabacum
or A. thaliana mitochondrial genome. In the A. thaliana
nuclear genome, the only matching sequence is that of the
atp9 gene copy in the large mitochondrial DNA insertion
found in chromosome 2.
As it is possible to design speciﬁc hammerhead ribo-
zymes to target virtually any RNA, such a strategy
could become a universal approach for both fundamental
studies of mitochondrial gene functions and for biotech-
nologies involving the manipulation of organelle gene ex-
pression. For example, breeding of major crops still needs
the development of new strategies for rapid and easy gen-
eration of CMS lines. The approach described here has the
potential to provide male sterile lines through either the
knockdown of a mitochondrial RNA or the organelle
import and translation of RNAs normally found in
CMS lines.
Allotopic expression and organelle import of custom-
ized RNAs offers a further important advantage, even
over a still unfeasible mitochondrial genetic transform-
ation, which is the versatility of nuclear promoters. The
latter will allow regulatable genetic manipulation of the
organelles, using an inducible promoter, or restriction of
the strategy with a tissue-speciﬁc promoter. Finally, since
tRNA import into mitochondria is a common phenom-
enon (24,25), the approach may prove to be suitable in
many organisms, including humans.
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